Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
Recruiting now · Not applicable
Conditions studied: Oral Cancer, Pharynx Cancer, Sleep Apnea, Snoring, Oral Squamous Cell Carcinoma
In brief
Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.
Key facts
- Study ID
- NCT05719779
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
- People needed
- 35
- Starts
- 2023-02-03
- Expected to finish
- 2025-12-30
- Last updated by the study team
- 2024-08-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- oropharyngeal cancer diagnosis
- 18 years of age and over
- female or male; ratio of 1/4 toward men
- had received RTH in the Department of Radiation Oncology,
- reporting snoring and/or respiratory cessation complaints during sleep,
You may not qualify if…
- pregnant or breastfeeding woman;
- edentation preventing retention of the oral appliance;
- taking opioid or anxiolitic type medications;
- history of major depression,
- uncontrolled hypertension,
- history of stroke;
- under treatment with CPAP for sleep apnea;
- regular and intense orofacial pain;
- under pharmacological treatment for insomnia;
- excessive alcohol or drug use (e.g., cannabis, opioid).
Where it is running
- CHUM — Montreal, Quebec, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.